389 related articles for article (PubMed ID: 23222563)
21. Genetic prognostication in uveal melanoma.
Dogrusöz M; Jager MJ
Acta Ophthalmol; 2018 Jun; 96(4):331-347. PubMed ID: 29105334
[TBL] [Abstract][Full Text] [Related]
22. Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.
Ambrosini G; Pratilas CA; Qin LX; Tadi M; Surriga O; Carvajal RD; Schwartz GK
Clin Cancer Res; 2012 Jul; 18(13):3552-61. PubMed ID: 22550165
[TBL] [Abstract][Full Text] [Related]
23. The biology of uveal melanoma.
Amaro A; Gangemi R; Piaggio F; Angelini G; Barisione G; Ferrini S; Pfeffer U
Cancer Metastasis Rev; 2017 Mar; 36(1):109-140. PubMed ID: 28229253
[TBL] [Abstract][Full Text] [Related]
24. Current molecular and clinical insights into uveal melanoma (Review).
Fallico M; Raciti G; Longo A; Reibaldi M; Bonfiglio V; Russo A; Caltabiano R; Gattuso G; Falzone L; Avitabile T
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649778
[TBL] [Abstract][Full Text] [Related]
25. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
26. PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma.
Field MG; Decatur CL; Kurtenbach S; Gezgin G; van der Velden PA; Jager MJ; Kozak KN; Harbour JW
Clin Cancer Res; 2016 Mar; 22(5):1234-42. PubMed ID: 26933176
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic signaling in uveal melanoma.
Park JJ; Diefenbach RJ; Joshua AM; Kefford RF; Carlino MS; Rizos H
Pigment Cell Melanoma Res; 2018 Nov; 31(6):661-672. PubMed ID: 29738114
[TBL] [Abstract][Full Text] [Related]
28. Uveal melanoma: Towards a molecular understanding.
Smit KN; Jager MJ; de Klein A; Kiliҫ E
Prog Retin Eye Res; 2020 Mar; 75():100800. PubMed ID: 31563544
[TBL] [Abstract][Full Text] [Related]
29. Germline BAP1 alterations in familial uveal melanoma.
Rai K; Pilarski R; Boru G; Rehman M; Saqr AH; Massengill JB; Singh A; Marino MJ; Davidorf FH; Cebulla CM; H Abdel-Rahman M
Genes Chromosomes Cancer; 2017 Feb; 56(2):168-174. PubMed ID: 27718540
[TBL] [Abstract][Full Text] [Related]
30. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
[TBL] [Abstract][Full Text] [Related]
31.
Horvathova Kajabova V; Soltysova A; Demkova L; Plesnikova P; Lyskova D; Furdova A; Babal P; Smolkova B
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639089
[TBL] [Abstract][Full Text] [Related]
32. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma.
Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594
[TBL] [Abstract][Full Text] [Related]
33. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.
Versluis M; de Lange MJ; van Pelt SI; Ruivenkamp CA; Kroes WG; Cao J; Jager MJ; Luyten GP; van der Velden PA
PLoS One; 2015; 10(3):e0116371. PubMed ID: 25764247
[TBL] [Abstract][Full Text] [Related]
34. Enhanced expression of son of sevenless homolog 1 is predictive of poor prognosis in uveal malignant melanoma patients.
Wang YS; Wu L
Ophthalmic Genet; 2019 Feb; 40(1):22-28. PubMed ID: 30714452
[TBL] [Abstract][Full Text] [Related]
35. Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas.
Schneider B; Riedel K; Zhivov A; Huehns M; Zettl H; Guthoff RF; Jünemann A; Erbersdobler A; Zimpfer A
Pathol Oncol Res; 2019 Oct; 25(4):1319-1325. PubMed ID: 29209985
[TBL] [Abstract][Full Text] [Related]
36. Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.
Minca EC; Tubbs RR; Portier BP; Wang Z; Lanigan C; Aronow ME; Triozzi PL; Singh A; Cook JR; Saunthararajah Y; Plesec TP; Schoenfield L; Cawich V; Sulpizio S; Schultz RA
Cancer Genet; 2014; 207(7-8):306-15. PubMed ID: 25442074
[TBL] [Abstract][Full Text] [Related]
37. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma.
Li J; Liu X; Li C; Wang W
J Cell Biochem; 2019 Aug; 120(8):12412-12421. PubMed ID: 30825222
[TBL] [Abstract][Full Text] [Related]
38. Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival.
Abdel-Rahman MH; Cebulla CM; Verma V; Christopher BN; Carson WE; Olencki T; Davidorf FH
Exp Eye Res; 2012 Jul; 100():26-31. PubMed ID: 22569040
[TBL] [Abstract][Full Text] [Related]
39. Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) promotes the aggressiveness of human uveal melanoma through dephosphorylation of CRMP2.
Duciel L; Anezo O; Mandal K; Laurent C; Planque N; Coquelle FM; Gentien D; Manneville JB; Saule S
Sci Rep; 2019 Feb; 9(1):2990. PubMed ID: 30816227
[TBL] [Abstract][Full Text] [Related]
40. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
Yang B; Gu A; Wu Y
Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]